Company
OssDsign AB
Headquarters: Uppsala, Sweden
Employees: 47
Market Cap
kr903.3 Million
SEK as of July 1, 2024
US$85.1 Million
Top Competitors by Market Capitalization
Industry: Medical Devices
| Company | Market Cap (USD) |
|---|---|
| Abbott | $178.02 B |
| Stryker Corporation | $126.48 B |
| Boston Scientific Corporation | $112.32 B |
| Medtronic | $98.95 B |
| Edwards Lifesciences Corporation | $55.63 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Detailed Description
OssDsign AB (publ) designs, manufactures, and sells implants and material technology for bone regeneration in Sweden, Germany, the United States, the United Kingdom, rest of Europe, and internationally. Its products include OSSDSIGN cranial, an implant solution for cranioplasty patients, as well as related accessories; OSSDSIGN facial to treat patients with complex facial skeletal defects; and OSSDSIGN Cranioplug for bone flap fixation and burr hole coverage, as well as nanosynthetic bone graft substitute for treating skeletal defect. The company was incorporated in 2011 and is headquartered in Uppsala, Sweden.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Stocks & Indices
OssDsign AB has the following listings and related stock indices.
Stock: OMX: OSSD wb_incandescent
Stock: FSX: 5J6 wb_incandescent